Cited by 99Antifungal resistance and susceptibilityFungal and yeast genetics researchYeasts and Rust Fungi Studies

Multi-omics Signature of Candida auris , an Emerging and Multidrug-Resistant Pathogen

Open access
Zamith-Miranda, Daniel, Heyman, Heino M., Cleare, Levi G., Couvillion, Sneha P., Clair, Geremy C., Bredeweg, Erin L., Gacser, Attila, Nimrichter, Leonardo +2 more·2019·mSystems

Published version of a preprint

Abstract

Abstract Candida auris is a recently described pathogenic fungus that is causing invasive outbreaks on all continents. The fungus is of high concern given the numbers of multidrug-resistant strains that have been isolated in distinct sites across the globe. The fact that its diagnosis is still problematic suggests that the spreading of the pathogen remains underestimated. Notably, the molecular mechanisms of virulence and antifungal resistance employed by this new species are largely unknown. In the present work, we compared two clinical isolates of C. auris with distinct drug susceptibility profiles and a Candida albicans reference strain using a multi-omics approach. Our results show that, despite the distinct drug-resistance profile, both C. auris strains appear to be very similar, albeit with a few notable differences. However, when compared to C. albicans both C. auris strains have major differences regarding their carbon utilization and downstream lipid and protein content, suggesting a multi-factorial mechanism of drug resistance. The molecular profile displayed by C. auris helps to explain the antifungal resistance and virulence phenotypes of this new emerging pathogen. Importance Candida auris was firstly described in Japan in 2009 and has now been the cause of significant outbreaks across the globe. The high number of isolates that are resistant to one or more antifungals, as well as the high mortality rates from patients with bloodstream infections, has caught the attention of the medical mycology, infectious disease and public health communities to this pathogenic fungus. In the current work, we performed a broad multi-omics approach on two clinical isolates isolated in New York, the most affected area in the USA and found that the omic profile of C. auris differs significantly from C. albicans . Besides our insights into C. auris carbon utilization and lipid and protein content, we believe that the availability of these data will enhance our ability to combat this rapidly emerging pathogenic yeast.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/msystems.00257-19

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinical features of C. auris infections include biofilm persistence on abiotic surfaces and skin, immune evasion, and antifungal drug resistance.

    “The clinical features of these infections include biofilm persistence on abiotic surfaces and skin, immune evasion, and antifungal drug resistance (7–12).”

    From Dual function of <i>Candida auris</i> mannosyltransferase, MNT5, in biofilm community protection from antifungal therapy and the host (2025) · cites this paper as [8]

    The Introduction reports C. auris on abiotic surfaces, biofilm production, resilience on hospital substrates, and antifungal resistance; the Results section on antifungal resistance documents a resistant clinical isolate. Our copy does not establish biofilm persistence on skin or immune evasion as features of C. auris infection. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • C. auris metabolism is likely to favour respiration because proteomic profiling demonstrated relative enrichment of TCA cycle and decreased glycolysis proteins compared to C. albicans.

    “C. auris metabolism is likely to favour respiration because proteomic profiling demonstrated relative enrichment of tricarboxylic acid (TCA) cycle and decreased glycolysis proteins compared to C. albicans [60].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zamith-Miranda, D., Heyman, H. M., Cleare, L. G., Couvillion, S. P., Clair, G. C., Bredeweg, E. L., Gacser, A., Nimrichter, L., Nakayasu, E. S., & Nosanchuk, J. D.
Affiliations
  • Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA
  • Pacific Northwest National Laboratory (US)
  • Albert Einstein College of Medicine (US)
  • Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA
  • Department of Microbiology, Interdisciplinary Excellence Centre, University of Szeged, Szeged, Hungary
  • Universidade Federal do Rio de Janeiro (BR)
Corresponding author
Nosanchuk, Joshua D.
Venue
mSystems
Published
2019-08-27
Volume
4
Issue
4
ISSN
2379-5077 (ISSN-L)
OpenAlex
W2950798794
Cited by
99
References
61
Citations by year
2026: 10 · 2025: 14 · 2024: 13 · 2023: 8 · 2022: 16 · 2021: 15 · 2020: 20 · 2019: 3
FWCI
10.35
Type
journal article
Language
en
Open access
Locations
  • mSystems (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
  • Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Research, Development and Innovation Office (K 123952)
  • GINOP (2-3-2-15-2016-00015, 2.3.3-15-2016-00006)
  • Ministry of Human Capacities - Hungary (20391-3/2018/FEKUSTRAT)
  • HHS | National Institutes of Health (R21 AI124797)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
Keywords
Candida auris, Candida albicans, multidrug resistance, antifungal resistance, multi-omics, clinical isolates, carbon utilization, lipid content, protein content, emerging fungal pathogens, bloodstream infection, comparative genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review